Except for its effects in controlling hyperglycemia in diabetic patients, GLP-1R agonists have been suggested as potential neuroprotective agents for neurologic disorders such as Alzheimer’s disease, Parkinson’s disease, cerebral ischemia, and traumatic injury in preclinical and clinical studies [11,12,13,14]. This evidence concerns the gene GLP1R and Alzheimer disease.